Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

BMJ oncology

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
BMJ Oncology|September 5, 2025
Inequities in lung cancer treatment: lessons from international variation in chemotherapy and radiotherapy useEmma L O'Dowd, Matthew Ej Callister
BMJ Oncology|March 25, 2025
Understandable, individualised information about risk is essential to help patients make fully informed decisions about breast cancer treatmentShelley Potter
BMJ Oncology|March 18, 2025
Re-evaluating testosterone therapy: new insights for men with familial prostate cancer riskOmer Onur Cakir, Fabio Castiglione
BMJ Oncology|January 31, 2025
Research priorities to improve cancer care for people with intellectual disabilities across the cancer continuumMaarten Cuypers, Deborah Cairns, Kathryn A Robb
BMJ Oncology|January 31, 2025
Determining fracture risk in patients exposed to immune checkpoint inhibitors: the time is nowJanet Helen Roberts
BMJ Oncology|January 31, 2025
Unlocking the predictive power of imaging biomarkers: predicting immune checkpoint therapy response in non-small cell lung cancer through baseline tumour vessel perfusionsSuraiya Dubash, Yat Tsang
BMJ Oncology|January 31, 2025
Geriatric oncology in LMICs: it is time to matureAmol Akhade, Haydee Verduzco-Aguirre, Bishal Gyawali
BMJ Oncology|January 31, 2025
Careful take-off by the EQ-5D-5L tool in lung cancer: fly little one, fly!Kurt G Tournoy
BMJ Oncology|January 31, 2025
Addressing the hidden toxicities of cancer: a call to action for clinicians, researchers and clinical trialistsRick Bangs
BMJ Oncology|January 31, 2025
Can PSA testing become appropriate public health policy?Peter Albertsen
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
BMJ Oncology|September 5, 2025
Inequities in lung cancer treatment: lessons from international variation in chemotherapy and radiotherapy useEmma L O'Dowd, Matthew Ej Callister
BMJ Oncology|March 25, 2025
Understandable, individualised information about risk is essential to help patients make fully informed decisions about breast cancer treatmentShelley Potter
BMJ Oncology|March 18, 2025
Re-evaluating testosterone therapy: new insights for men with familial prostate cancer riskOmer Onur Cakir, Fabio Castiglione
BMJ Oncology|January 31, 2025
Research priorities to improve cancer care for people with intellectual disabilities across the cancer continuumMaarten Cuypers, Deborah Cairns, Kathryn A Robb
BMJ Oncology|January 31, 2025
Determining fracture risk in patients exposed to immune checkpoint inhibitors: the time is nowJanet Helen Roberts
BMJ Oncology|January 31, 2025
Unlocking the predictive power of imaging biomarkers: predicting immune checkpoint therapy response in non-small cell lung cancer through baseline tumour vessel perfusionsSuraiya Dubash, Yat Tsang
BMJ Oncology|January 31, 2025
Geriatric oncology in LMICs: it is time to matureAmol Akhade, Haydee Verduzco-Aguirre, Bishal Gyawali
BMJ Oncology|January 31, 2025
Careful take-off by the EQ-5D-5L tool in lung cancer: fly little one, fly!Kurt G Tournoy
BMJ Oncology|January 31, 2025
Addressing the hidden toxicities of cancer: a call to action for clinicians, researchers and clinical trialistsRick Bangs
BMJ Oncology|January 31, 2025
Can PSA testing become appropriate public health policy?Peter Albertsen
Pageof 23